Cefotaxime - Pediatric Dosing

Note
Currently on long-term backorder without an estimated release date

Creatinine Clearance >50mL/min/1.73m²

50 mg/kg/dose Q6H

Creatinine Clearance <20mL/min/1.73m²

25 mg/kg/dose Q6H

Creatinine Clearance <10mL/min/1.73m²

No change

< 29 weeks postmenstrual age AND ≤28 days old

50 mg/kg/dose IV Q12H

< 29weeks postmenstrual age AND > 28 days old

50 mg/kg/dose IV Q8H

30-36 weeks postmenstrual age AND ≤14 days old

50 mg/kg/dose IV Q12H

30-36 weeks postmenstrual age AND >14 days old

50 mg/kg/dose IV Q8H

37-44 weeks postmenstrual age AND ≤7 days old

50 mg/kg/dose IV Q12H

37-44 weeks postmenstrual age AND >7 days old

50 mg/kg/dose IV Q8H

≥45 weeks postmenstrual age

50 mg/kg/dose IV Q6H

2g Q4H